5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE
Compound with spectra: 1 NMR
![5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE](/api/compound/CtreINNaY8Y.png?ph=true&h=300&w=458 "5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE")
| SpectraBase Compound ID | CtreINNaY8Y |
|---|---|
| InChI | InChI=1S/C17H16FN3OS/c1-17(7-8-18)13-9-11(3-5-14(13)20-16(23)22-17)15-6-4-12(10-19)21(15)2/h3-6,9H,7-8H2,1-2H3,(H,20,23) |
| InChIKey | UECRKPRISWFXTM-UHFFFAOYSA-N |
| Mol Weight | 329.39 g/mol |
| Molecular Formula | C17H16FN3OS |
| Exact Mass | 329.099811 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
5-[4-(3-FLUOROPROPYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE
1-PHENYL-PENTALONGIN
5,6-Dihydro-8H,13aH-pyrido[3,2-e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-8-thione
Methyl 3-{1-[methyl(phenethyl)amino]indolizin-3-yl}benzoate
OKLXWNDODXFSCM-KOFCSXQLSA-N
9-[3.beta.-Acetamido-2.alpha.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
9-[3.beta.-Acetamido-2.beta.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
(2R,4S)-N-(3-chlorophenyl)-4-(hexanoylamino)-2,6-dimethyl-3,4-dihydro-1(2H)-quinolinecarboxamide
ETHYL-5-PHENYL-4-FLUORO-3-CYANOMETHYL-1-BENZYL-1H-PYRROLE-2-CARBOXYLATE
1-(3,5-dimethylphenyl)-4-[(4Z)-4-[(2-sulfanylidenepropyl)imino]-6,8-dioxabicyclo[3.2.1]octan-2-yl]-4,5-dihydro-1H-1,2,3,4-tetrazole-5-thione
| Title | Journal or Book | Year |
|---|---|---|
| Imaging Progesterone Receptor in Breast Tumors: Synthesis and Receptor Binding Affinity of Fluoroalkyl-Substituted Analogues of Tanaproget | Journal of Medicinal Chemistry | 2010 |